Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 817,044 | 799,712 | 749,672 | 743,195 | 650,138 |
| Cost of Goods | 115,673 | 123,407 | 114,842 | 119,838 | 112,481 |
| Gross Profit | 701,371 | 676,305 | 634,830 | 623,357 | 537,657 |
| Operating Expenses | 537,502 | 510,761 | 430,630 | 499,118 | 408,669 |
| Operating Income | 164,542 | 165,951 | 205,042 | 125,077 | 129,469 |
| Other Income | 147,501 | 27,507 | 2,458 | 14,025 | 2,657 |
| Pre-tax Income | 312,043 | 193,458 | 207,500 | 139,102 | 132,126 |
| Income Tax | 112,407 | 61,113 | 56,029 | 46,274 | 42,822 |
| Net Income Continuous | 199,636 | 132,345 | 151,471 | 92,828 | 89,304 |
| Net Income | $151,981 | $132,345 | $151,471 | $92,828 | $89,304 |
| EPS Basic Total Ops | 0.15 | 0.13 | 0.15 | 0.09 | 0.09 |
| EPS Basic Continuous Ops | 0.19 | 0.13 | 0.15 | 0.09 | 0.09 |
| EPS Diluted Total Ops | 0.14 | 0.13 | 0.15 | 0.09 | 0.09 |
| EPS Diluted Continuous Ops | 0.18 | 0.13 | 0.15 | 0.09 | 0.09 |
| EBITDA(a) | $240,597 | $237,806 | $278,058 | $195,003 | $198,253 |